2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha has been researched along with Thrombophilia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abramov, A; De Raucourt, E; Durst, R; Eldor, A; Gillis, S; Godefray, YC; Goldfarb, A; Guillin, MC; Hy-Am, E; MacLouf, J; Rachmilewitz, EA | 1 |
1 other study(ies) available for 2,3-dinor-6,15-diketo-13,14-dihydroprostaglandin f1alpha and Thrombophilia
Article | Year |
---|---|
A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood.
Topics: Adolescent; Adult; beta-Thalassemia; Blood Coagulation Factors; Child; Child, Preschool; Complement Inactivator Proteins; Glycoproteins; Humans; Mutation; Plasminogen; Prostaglandins F, Synthetic; Protein C; Protein S; Receptors, Complement; Thrombophilia; Thromboxane B2 | 1999 |